Skip to content

CD36 Ateromase

There are no reviews yet.

Heart and circulation Ref. CMPH0022

Composition

Amounts per 4 capsules:

Ingredients Daily amounts
Lapacho bark (powder) 1,160 mg
Tabetin® (lapacho extract) 40 mg

CD36 Ateromase — Description

CD36 Ateromase is based on a combination of two complementary forms of lapacho: 1,160 mg of bark powder and 40 mg of Tabetin® extract per four capsules. The powder provides the bark’s plant matrix, while the extract is the concentrated, targeted fraction of the formula.


A formula focused on lipid and vascular balance

Cholesterol is transported in the blood by various particles, including LDL. These fulfil an essential function, but when retained in the arterial wall and modified by oxidation, they can trigger a local reaction.

Macrophages, cells responsible for recognising and eliminating certain unwanted elements, notably capture oxidised LDL through receptors such as CD36. When this uptake becomes excessive, macrophages gradually accumulate lipids. They can then sustain the production of inflammatory messengers within the vascular wall.

CD36 is therefore not something to be eliminated: it is a useful physiological receptor. The aim of this formula is instead to support the regulation of its activity when cells are exposed to a large amount of modified lipids. This positioning makes CD36 Ateromase a supplement for people attentive to their circulation and the maintenance of a balanced vascular environment.


Tabetin®, the concentrated fraction of the formula

Tabetin® is an extract of Handroanthus impetiginosus described by the manufacturer as patented, concentrated and standardised. It is the active ingredient mainly associated with the formula’s positioning on the CD36 receptor.

This pathway acts at two complementary levels:

  •  recognition and entry of modified LDL into certain cells;
  •  activation of cellular relays, including NF-κB, which govern the production of several inflammatory messengers.

By supporting modulation of this pathway, the extract forms part of an approach to supporting lipid and inflammatory balance at vascular level.


Bark powder to preserve the plant matrix

The formula also provides 1,160 mg of lapacho bark powder per four capsules. A plant powder is obtained by drying and then grinding the raw material. Unlike an extract, it retains a broader matrix without selectively concentrating a particular family of constituents.

Handroanthus impetiginosus bark is known to contain various families of plant substances, including naphthoquinones such as lapachol and beta-lapachone, as well as phenolic compounds, flavonoids and other secondary constituents. These molecules are notably studied for their interaction with oxidation phenomena and cellular signalling pathways.

The bark powder therefore complements the targeted action of the extract by providing the lapacho phytocomplex.


Bark from the South American tradition

Lapacho is a tree in the Bignoniaceae family, now recognised under the botanical name Handroanthus impetiginosus. It has also been referred to in the literature as Tabebuia impetiginosa and Tabebuia avellanedae.

Native to an area extending from central Mexico to tropical South America, it is also known as pau d’arco, taheebo, ipê-roxo or red lapacho. Its inner bark is traditionally prepared as a decoction in several regions of South America. The biomedical literature dates the first documented mentions of its use to the late 19th century.

In CD36 Ateromase, this traditional botanical material is offered in a modern, precisely dosed form combining bark powder and concentrated extract.


The formula’s distinctive features

  •  Two forms of lapacho combined in a single serving.
  •  1,160 mg of bark powder per four capsules.
  •  40 mg of concentrated Tabetin® extract per four capsules.
  •  Specific positioning around the CD36 receptor and modified lipids.
  •  Vegetable capsules suitable for vegetarian and vegan diets.
  •  A formula free from active ingredients of animal origin.


Who is this product for?

CD36 Ateromase may be particularly suitable for:

  •  people wishing to support their circulatory comfort through a botanical approach;
  •  people attentive to maintaining their vascular and lipid balance;
  •  during periods when lifestyle, sedentary habits or an unbalanced diet lead to particular attention being paid to circulation;
  •  those looking for a formula combining a whole plant powder with a concentrated extract;
  •  vegetarians and vegans.


What does the science say?

The publication most directly related to the positioning of CD36 Ateromase concerns the influence of a Handroanthus impetiginosus extract on the CD36 receptor. This is not a clinical trial, but research on human cells enabling precise exploration of the mechanism highlighted.

The objective

The researchers wanted to determine whether an extract of Handroanthus impetiginosus could influence:

  •  the production of inflammatory messengers;
  •  activation of NF-κB, a relay that controls several inflammatory reactions;
  •  expression of the CD36 receptor;
  •  the entry into macrophages of cholesterol from modified LDL.

The procedure

The work was conducted in Italy by university teams from Padua and Parma. Published online in 2023, it appeared in an issue of the journal Natural Product Research in 2024.

No volunteers took part: the researchers used human THP-1 cells, a model of monocytes that can be transformed into macrophage-like cells.

The cells received different concentrations of a Handroanthus impetiginosus extract, up to 200 µg/mL. They were compared with untreated control cells.

The observed results

Even at the maximum concentration of 200 µg/mL, the extract did not reduce cell viability under the experimental conditions.

The researchers then observed:

  •  a decrease in several pro-inflammatory messengers;
  •  migration of NF-κB into the cell nucleus;
  •  a progressive reduction in CD36 expression, at both messenger RNA and protein levels;
  •  a decrease in the uptake of cholesterol from modified LDL.

These results provide a coherent biological explanation for positioning a lapacho extract around CD36, modified lipids and the associated inflammatory signals.

Full reference: Rossi I, Barollo S, Bertazza L, Mondin A, Pedron MC, Marodin G, Lupo MG, Palumbo M, Adorni MP, Mian C, Pezzani R, Ferri N. “Effects of Handroanthus impetiginosus (Mart. ex DC.) Mattos extract on inflammatory, immune, atherogenic profile and differentiation in THP-1 cell line.” Natural Product Research. 2024;38(19):3411-3416. Electronic publication: 2023. DOI 10.1080/14786419.2023.2244125 — PubMed PMID 37548308.

Reviews

Product Details

Reference
CMPH0022
In stock
1099 Items
Format
Capsule